ASSOCIATION OF URIC ACID PLASMA WITH HYPERTENSION, CHRONIC KIDNEY DISEASE, AND METABOLIC SYNDROME IN TYPE 2 DIABETIC PATIENTS
Main Article Content
Abstract
Background: Studies have shown an association between hyperuricemia, type 2 diabetes, and metabolic syndrome (MetS). Besides, increased uric acid is also associated with the progression of chronic kidney disease (CKD), hypertension, and MetS. A few recent reports have evaluated the relationship between uric acid and hypertension, chronic kidney disease, or MetS syndrome, but they are unclear. Method: Cross-sectional study, collecting data on serum uric acid and comorbidities such as hypertension, MetS, and CKD in type 2 diabetic patients who have been treated at Le Van Thinh Hospital. Results: A total of 156 patients with type 2 diabetes, aged 18 years and older, participated in this study. The mean age of participants was 64.9±12.3; 52.6% of whom were males. The average serum uric acid level was 6.5 mg/dL, and the rate of hyperuricemia was 43%. In the hyperuricemia group, there were a higher number of accompanying diseases. Uric acid was positively correlated with blood glucose in the chronic kidney disease group (r = 0.4, p = 0.02), with serum creatinine and urea levels in the hypertension group (r = 0.26, p = 0.004, and r = 0.32, p = 0.009), and in the MetS group (r = 0.42, p = 0.001). Conclusion: Hyperuricemia in patients with type 2 diabetes is associated with increased rates of hypertension, chronic kidney disease, and metabolic syndrome.
Article Details
Keywords
uric acid, hypertension, chronic kidney disease, metabolic syndrome, diabetes
References
2. Benchao Li, Liangkai Chen, Xueting Hu, et al. Association of serum uric acid with all-cause and cardiovascular mortality in diabetes. Diabetes Care 2023; 46 (2): 425–433.
3. Wang Y, Lu J. The Management of Diabetes with Hyperuricemia: Can We Hit Two Birds with One Stone? J Inflamm Res. 2023; 16: 6431-6441. https://doi.org/10.2147/JIR.S433438.
4. Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS. Uric acid and the risks of kidney failure and death in individuals with CKD. Am. J. Kidney Dis. Off. J. Natl. Kidney Found; 2018, 71:362–370.
5. Raya-Cano E, Vaquero-Abellán M, Molina-Luque R, et al. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. Sci Rep. 2022; 12(1): 18412.
6. Bartáková V, Kuricová K, Pácal L, et al. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus. J Diabetes Complications. 2016; 30(7):1300–1307.
7. Sun, H. et al. The longitudinal increments of serum alanine aminotransferase increased the incidence risk of metabolic syndrome: A large cohort population in China. Clin. Chim. Acta 2019, 488, 241–247.
8. Zaha CD, et al. Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome. Exp. Ther. Med. 2020, 20(1), 121–128.
9. Arersa KK, Wondimnew T, Welde M, Husen TM. Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients Attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes. 2020; 13: 2059-2067.
10. Trần Đặng Đăng Khoa, Ngô Hoàng Toàn, Nguyễn Trung Kiên. Khảo sát tỷ lệ tăng acid uric máu và một số yếu tố liên quan ở bệnh nhân đái tháo đường typ 2 từ 40 tuổi trở lên tại Cần Thơ. Tạp chí Y học Việt Nam. 2023; 532 (1): 343-347.